Vetigenics
2929 Arch St Fl 4 Lab 436 Philadelphia, Pennsylvania 19104, UShttps://www.vetigenics.com/Therapeutics
Vetigenics is a clinical-stage animal health biotechnology company focused on developing antibody therapeutics for pets. The company is advancing therapies targeting autoimmune diseases, obesity, and allergies, aiming to improve pet health through innovative biotechnological solutions.
Leadership & Board
- Current Number of Employees
- 13
- Current LinkedIn Followers
- 979
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $6M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $6M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Employee Trend
Vetigenics had 13 employees as of October 12, 2026. The number of employees increased by 2 (18.18%) week-over-week.
13Latest Employee Count
2(18.18%)Week-Over-Week Change
Social Trend
Vetigenics had 979 followers as of October 12, 2026. The number of followers increased by 4 (0.41%) week-over-week.
979Latest Followers Count
4(0.41%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 03, 2025 | Seed Round | $6.00M | ― |
Similar Companies
A snapshot of private companies similar to Vetigenics, helping you discover and navigate related company profiles.
Related News and Analysis
